McCloskey, J. K., Pullarkat, V. A., Mannis, G. N., Lin, T. L., Strickland, S. A., Fathi, A. T., … Levis, M. J. (2022). V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).

McCloskey, James K., Vinod A. Pullarkat, Gabriel N. Mannis, Tara L. Lin, Stephen Anthony Strickland, Amir Tahmasb Fathi, Harry Paul Erba, et al. “V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.

McCloskey JK, Pullarkat VA, Mannis GN, Lin TL, Strickland SA, Fathi AT, et al. V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.

McCloskey, James K., et al. “V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.

McCloskey JK, Pullarkat VA, Mannis GN, Lin TL, Strickland SA, Fathi AT, Erba HP, Faderl S, Chakravarthy D, Lutska Y, Chandrasekaran V, Cheung R, Levis MJ. V-FAST master trial: Preliminary results of treatment with CPX-351 plus midostaurin in adults with newly diagnosed FLT3-mutated acute myeloid leukemia. JOURNAL OF CLINICAL ONCOLOGY. 2022.